Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Bandaram Pharma Packtech's Revenue for the
three
months ended in Jun. 2026 was ₹239.5 Mil. Bandaram Pharma Packtech's average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹313.5 Mil.
Hence, Bandaram Pharma Packtech's Receivables Turnover for the
three
months ended in Jun. 2026 was 0.76.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Bandaram Pharma Packtech Receivables Turnover Related Terms
Bandaram Pharma Packtech Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Bandaram Pharma Packtech's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524602 vs SW, AMCR, PKG: Receivables Turnover Comparison
For the Packaging & Containers subindustry, Bandaram Pharma Packtech's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bandaram Pharma Packtech Receivables Turnover vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Bandaram Pharma Packtech's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Bandaram Pharma Packtech's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bandaram Pharma Packtech (BOM:524602) has a Receivables Turnover of 0.76 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bandaram Pharma Packtech and its competitors. According to the industry distribution chart, Bandaram Pharma Packtech ranks #356 out of 403 companies in the Packaging & Containers industry, placing it in the top 88.3%.
Is Bandaram Pharma Packtech's Receivables Turnover too high?
Bandaram Pharma Packtech's current Receivables Turnover is 0.76. The Packaging & Containers industry median Receivables Turnover is 5.45. Bandaram Pharma Packtech's value of 0.76 is 86.1% below this industry median. Based on the distribution chart, Bandaram Pharma Packtech ranks #356 out of 403 companies in the Packaging & Containers industry, which is in the bottom quartile relative to peers. Overall, Bandaram Pharma Packtech has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bandaram Pharma Packtech's Receivables Turnover compare to SW and AMCR?
According to the Packaging & Containers industry distribution chart, Bandaram Pharma Packtech ranks #356 out of 403 companies for Receivables Turnover. This places Bandaram Pharma Packtech in the lower half of its industry. The industry median Receivables Turnover is 5.45. Bandaram Pharma Packtech's value of 0.76 is 86.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Packaging & Containers company?
The median Receivables Turnover among Packaging & Containers companies is 5.45, based on 403 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bandaram Pharma Packtech's current Receivables Turnover of 0.76 is 86.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bandaram Pharma Packtech and its competitors. For the Packaging & Containers industry, the median Receivables Turnover is 5.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bandaram Pharma Packtech's current Receivables Turnover is 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bandaram Pharma Packtech stock overvalued right now?
Based on GuruFocus' analysis, Bandaram Pharma Packtech (BOM:524602) is currently considered Possible Value Trap. The stock's GF Value™ is ₹50.85, compared to a current price of ₹20.97 — trading 58.8% below its estimated fair value. The current Receivables Turnover is 0.76 and 86.1% below the Packaging & Containers industry median of 5.45. Bandaram Pharma Packtech's overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Bandaram Pharma Packtech (BOM:524602), the current Receivables Turnover is 0.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bandaram Pharma Packtech (BOM:524602) Overvalued in 2026?
Based on GuruFocus' analysis, Bandaram Pharma Packtech stock appears to be undervalued.
The current stock price of ₹20.97 is trading 58.8% below its estimated GF Value™ of ₹50.85.
GuruFocus considers Bandaram Pharma Packtech to be Possible Value Trap.
Key valuation signals for BOM:524602:
Receivables Turnover: 0.76
GF Value™: ₹50.85 vs. price of ₹20.97 (58.8% below fair value)
Industry Position: 86.1% below the Packaging & Containers median (#356 of 403)
No single metric tells the full story. See the BOM:524602 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bandaram Pharma Packtech Ltd is an India-based company engaged in the manufacturing of paper products and packing materials with more focus on catering to the needs of the pharma, food, and beverages industry apart from undertaking logistics business. The company is engaged in the Trading of Paper boards and Recycled Waste Paper. The company has only one business segment procurement and supply of recycled paper.
34GF Score
Get the complete analysis for BOM:524602
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524602 has been successfully added to your 
